[{"orgOrder":0,"company":"PEGASUS LABORATORIES INC","sponsor":"Not Applicable","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Small molecule","year":"2021","type":"Not Applicable","leadProduct":"Potassium Bromide","moa":"Adenosine kinase","graph1":"Neurology","graph2":"Approved","graph3":"PEGASUS LABORATORIES INC","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Chewable tablet","sponsorNew":"PEGASUS LABORATORIES INC \/ Not Applicable","highestDevelopmentStatusID":"12","companyTruncated":"PEGASUS LABORATORIES INC \/ Not Applicable"}]

Find Clinical Drug Pipeline Developments & Deals by PEGASUS LABORATORIES INC

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Antibody Engineering
                          Not Confirmed
                          Antibody Engineering
                          Not Confirmed

                          Details : KBro-Vet-CA1 meets the criteria of conditional approval under the expanded authority, as there is currently no animal drug approved and marketed in the U.S. for the treatment of idiopathic epilepsy in dogs.

                          Brand Name : KBroVet-CA1

                          Molecule Type : Small molecule

                          Upfront Cash : Not Applicable

                          January 14, 2021

                          Lead Product(s) : Potassium Bromide

                          Therapeutic Area : Neurology

                          Highest Development Status : Approved

                          Sponsor : Not Applicable

                          Deal Size : Not Applicable

                          Deal Type : Not Applicable

                          blank